Immugenyx and Janssen to develop humanised mouse model of lupus
UK biopharma Hemogenyx Pharmaceuticals has signed a deal with Janssen Research & Development to create a humanised mouse model of lupus.
Read More
Tag: humanised mouse
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
